Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- Role of Soy Supplementation in Prostate Cancer Development: Complete Statistical AnalysisIndependent statistical analysis of Role of Soy Supplementation in Prostate Cancer Development: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00255125).
- Role of the Supraspinal Opioidergic Circuit in Prefrontal TMS-Induced Analgesia: Complete Statistical AnalysisIndependent statistical analysis of Role of the Supraspinal Opioidergic Circuit in Prefrontal TMS-Induced Analgesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01643798).
- Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303: Complete Statistical AnalysisIndependent statistical analysis of Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Rollover Study of BMS-354825 in Patients With CML and Ph+ALL: Complete Statistical AnalysisIndependent statistical analysis of Rollover Study of BMS-354825 in Patients With CML and Ph+ALL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01030718).
- Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis: Complete Statistical AnalysisIndependent statistical analysis of Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor: Complete Statistical AnalysisIndependent statistical analysis of Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ROMEO (Rosuvastatin in Metabolic syndrOme): Complete Statistical AnalysisIndependent statistical analysis of ROMEO (Rosuvastatin in Metabolic syndrOme): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00395486).
- Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine: Complete Statistical AnalysisIndependent statistical analysis of Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS): Complete Statistical AnalysisIndependent statistical analysis of Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ROPIndependent statistical analysis of Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00634972).
- ROP1Independent statistical analysis of Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ropivacaine Block Alone or With Perineural or Systemic Dexamethasone for Pain in Shoulder Surgery: Complete Statistical AnalysisIndependent statistical analysis of Ropivacaine Block Alone or With Perineural or Systemic Dexamethasone for Pain in Shoulder Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ROSEIndependent statistical analysis of A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Rotator Cuff Tears in Hemiplegic Shoulder: Complete Statistical AnalysisIndependent statistical analysis of Rotator Cuff Tears in Hemiplegic Shoulder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00998868).
- ROUTE-T1DIndependent statistical analysis of Research on Optimizing the Use of Technology With Education: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05564481).
- ROXI-VTE IIIndependent statistical analysis of A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size…
- RPCWIndependent statistical analysis of Prevention of Alcohol-related Sexual Revictimization in College: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05257603).
- rPlan Multimedia Dual Protection Intervention to Reduce Health Disparities: Complete Statistical AnalysisIndependent statistical analysis of rPlan Multimedia Dual Protection Intervention to Reduce Health Disparities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02498067).
- RRRIndependent statistical analysis of Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy.: primary endpoint…
- RSLV-132Independent statistical analysis of A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03247686).
- RSV OA=ADJ-023Independent statistical analysis of A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant…
- RSVHRIndependent statistical analysis of A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery: Complete Statistical AnalysisIndependent statistical analysis of RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- RTGIndependent statistical analysis of Room to Grow Evaluation for Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04226053).
- rTMS Bimodal Treatment For Tinnitus: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of rTMS Bimodal Treatment For Tinnitus: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01590264).
- rTMS Combined With BWSTT in Stroke With Body Weight Supported Treadmill Training (BWSTT) After Stroke: Complete Statistical AnalysisIndependent statistical analysis of rTMS Combined With BWSTT in Stroke With Body Weight Supported Treadmill Training (BWSTT) After Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- rTMSECTIndependent statistical analysis of rTMS in Treatment Resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02080507).
- RUBATOIndependent statistical analysis of Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial): primary endpoint results, effect…
- Rural Home Hospital: Proof of Concept: Complete Statistical AnalysisIndependent statistical analysis of Rural Home Hospital: Proof of Concept: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04531280).
- Rural NDPPIndependent statistical analysis of The National Diabetes Prevention Program in Rural Communities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05387434).
- Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF): Complete Statistical AnalysisIndependent statistical analysis of Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02267278).
- Ruxolitinib for Adult T-Cell Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Ruxolitinib for Adult T-Cell Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01712659).
- Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ruxolitinib in Seborrheic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of Ruxolitinib in Seborrheic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05787860).
- RVD LiteIndependent statistical analysis of Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01782963).
- RVDDIndependent statistical analysis of Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C: Complete Statistical AnalysisIndependent statistical analysis of S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00475176).
- S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma: primary endpoint results, effect estimate with confidence…
- S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.: Complete Statistical AnalysisIndependent statistical analysis of S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction: Complete Statistical AnalysisIndependent statistical analysis of S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction: primary endpoint results, effect estimate with confidence…
- S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer: Complete Statistical AnalysisIndependent statistical analysis of S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate…
- S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with…
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer: Complete Statistical AnalysisIndependent statistical analysis of S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib: Complete Statistical AnalysisIndependent statistical analysis of S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib: primary endpoint results, effect estimate with…
- S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma: Complete Statistical AnalysisIndependent statistical analysis of S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00003590).